Description:

NHS Framework agreement for the supply of Recombinant Factor VIII products for the treatment of bleeding disorders. Deliveries will be required over a period of 2 years, with options to extend up to a further 24 months.

Awarded to:

CM/PHS/11/5261

For details of the awarded suppliers please see section V1.2, ()

Download full details as .pdf

The Buyer:

The Secretary of State for Health acting through the Commercial Medicines Unit (part of the Department of Health)

CPV Code(s):

33141510 - Blood products

33141530 - Blood coagulants

33620000 - Medicinal products for the blood, blood-forming organs and the cardiovascular system